Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
TEVAPHARMIND SP ADR (NY: TEVA)
32.73 USD  -0.03 (-0.09%)
Streaming Delayed Price  /  Updated: 10:40 AM EDT, Jul 26, 2017  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 975,914
Open 32.78
Bid (Size) 32.74 (600)
Ask (Size) 32.75 (500)
Prev. Close 32.76
Today's Range 32.58 - 32.87
52wk Range 27.59 - 55.79
Shares Outstanding 1,016,000,000
Dividend Yield 4.16%
Performance
YTD
-12.67%
-12.67%
1 Month
-0.67%
-0.67%
3 Month
+6.40%
+6.40%
6 Month
+0.40%
+0.40%
1 Year
-39.76%
-39.76%
Top News
More News
Teva Announces the Launch of Generic Vagifem® in the United States
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of Vagifem®1 (estradiol vaginal inserts), 10 mcg in the U.S. Read More
from Business Wire News Releases
Stull, Stull & Brody Announces Class Action Lawsuit on Behalf of Employee Benefit Plan Purchasers of American Depository Shares of Teva Pharmaceutical Industries Limited
Stull, Stull & Brody ("SS&B") announces that a class action lawsuit was commenced in the United States District Court for the Southern District of Ohio on behalf of purchasers of Teva Pharmaceutical... Read More
from GlobeNewswire News Releases
More News
Read More
NICE Recommends CINQAERO® (reslizumab) for the Treatment of Severe Eosinophilic Asthma
from Business Wire News Releases
Technical Reports on Drug Makers Equities -- Teva Pharma, Endo, Ionis Pharma, and Amarin
from PR Newswire
Pace of rate hikes may slow, markets close higher
category Market News
from MarketMinute.com Market Updates
BRIEF-Teva announces launch of generic vagifem in U.S.
category companyNews
from Reuters: Company News
Teva Pharm to reduce workforce in Israel, mainly in production
category companyNews
from Reuters: Company News
PRESS DIGEST- Financial Times - July 18
category companyNews
from Reuters: Company News
3 Stocks the Smartest Investors Are Buying Right Now
category TEVA , NEP , EGRX , and 1 more.
from Motley Fool
U.S. court upholds Takeda patent on cancer drug Velcade
category companyNews
from Reuters: Company News
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back
category NYSE:VRX , NYSE:TEVA , Stocks to Buy
from InvestorPlace - Latest Headlines
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial